Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Eric Sparkes"'
Autor:
Eric Sparkes, Rochelle Boyd, Shuli Chen, Jack W. Markham, Jia Lin Luo, Tahira Foyzun, Humayra Zaman, Charlotte Fletcher, Ross Ellison, Iain S. McGregor, Marina J. Santiago, Felcia Lai, Roy R. Gerona, Mark Connor, David E. Hibbs, Elizabeth A. Cairns, Michelle Glass, Adam Ametovski, Samuel D. Banister
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Synthetic cannabinoid receptor agonists (SCRAs) continue to make up a significant portion new psychoactive substances (NPS) detected and seized worldwide. Due to their often potent activation of central cannabinoid receptors in vivo, use of SCRAs can
Externí odkaz:
https://doaj.org/article/8bb387539a3c4fa38d68649acedf0eb4
Autor:
Hunter D. J. Webb, David B. Finlay, Shuli Chen, Andrea J. Vernall, Eric Sparkes, Samuel D. Banister, Rhonda J. Rosengren, Michelle Glass
Publikováno v:
Forensic Toxicology. 41:114-125
PurposeAMB-FUBINACA is a synthetic cannabinoid receptor agonist (SCRA) which is primarily metabolised by hepatic enzymes producing AMB-FUBINACA carboxylic acid. The metabolising enzymes associated with this biotransformation remain unknown. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd82185a374fbebef38f2076d75d5f4c
https://doi.org/10.1007/s11419-022-00649-3
https://doi.org/10.1007/s11419-022-00649-3
Autor:
Roy Gerona, Michelle Glass, Marie Deventer, Rochelle Boyd, Shuli Chen, Felcia Lai, Ross Ellison, Lewis J. Martin, Elizabeth A. Cairns, David E. Hibbs, Katharina Elisabeth Grafinger, Eric Sparkes, V. Auwaerter, Samuel D. Banister, Richard C. Kevin, Iain S. McGregor, Christophe P. Stove
Publikováno v:
RSC Med Chem
Synthetic cannabinoid receptor agonists (SCRAs) remain one the most prevalent classes of new psychoactive substances (NPS) worldwide, and examples are generally poorly characterised at the time of first detection. We have synthesised a systematic lib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a320cd7cb08acb3ad4c342d809f21558
https://doi.org/10.1039/d1md00242b
https://doi.org/10.1039/d1md00242b
Autor:
Liesl K. Janssens, Adam Ametovski, Eric Sparkes, Rochelle Boyd, Felcia Lai, Callan J. Maloney, Dane Rhook, Roy R. Gerona, Matthew Connolly, Huiling Liu, David E. Hibbs, Elizabeth A. Cairns, Samuel D. Banister, Christophe P. Stove
Publikováno v:
ACS chemical neuroscience. 14(1)
Over 200 synthetic cannabinoid receptor agonists (SCRAs) have been identified as new psychoactive substances. Effective monitoring and characterization of SCRAs are hindered by the rapid pace of structural evolution. Ahead of possible appearance on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163222e00716076b990b1ce0349b7663
https://pubmed.ncbi.nlm.nih.gov/36530139
https://pubmed.ncbi.nlm.nih.gov/36530139
Autor:
Elizabeth A. Cairns, Benedikt Pulver, Patrick Osamu Juchli, Marthe M Vandeputte, Belal Haschimi, Eric Sparkes, Annelies Cannaert, Volker Auwärter, Samuel D. Banister, Christophe P. Stove, Adam Ametovski, Katharina Elisabeth Grafinger
Publikováno v:
DRUG TESTING AND ANALYSIS
The present work is the last of a three-part study investigating a panel of 30 systematically designed synthetic cannabinoid receptor agonists (SCRAs) including features such as the 4-pentenyl tail and varying head groups including amides and esters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734c32016f8b7bca3b94bc862fb47d73
https://doi.org/10.1002/dta.3054
https://doi.org/10.1002/dta.3054
Autor:
Katharina Elisabeth Grafinger, Volker Auwärter, Samuel D. Banister, Christophe P. Stove, Annelies Cannaert, Ross Ellison, Roy Gerona, Eric Sparkes, Adam Ametovski, Elizabeth A. Cairns, Jia Lin Luo, Edward Pike
Publikováno v:
Drug Testing and Analysis. 13:1383-1401
Synthetic cannabinoid receptor agonists (SCRAs) are one of the largest and most structurally diverse classes of new psychoactive substances (NPS). Despite this, pharmacological data are often lacking following the identification of a new SCRA in drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97e80ffdbb118ca58e8a1e4e48fc02fd
https://doi.org/10.1002/dta.3037
https://doi.org/10.1002/dta.3037
Autor:
Volker Auwärter, Samuel D. Banister, Annelies Cannaert, Elizabeth A. Cairns, Adam Ametovski, Eric Sparkes, Christophe P. Stove, Katharina Elisabeth Grafinger
Publikováno v:
Drug Testing and Analysis. 13:1402-1411
Synthetic cannabinoid receptor agonists (SCRAs) are the second largest class of new psychoactive substances (NPS) and are associated with serious adverse effects and even death. Despite this, little pharmacological data are available for many of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3880a3b0ed7eccacfcaf4d8c52410c3f
https://doi.org/10.1002/dta.3035
https://doi.org/10.1002/dta.3035
Autor:
Jack, Markham, Eric, Sparkes, Rochelle, Boyd, Shuli, Chen, Jamie J, Manning, David, Finlay, Felcia, Lai, Eila, McGregor, Callan J, Maloney, Roy R, Gerona, Mark, Connor, Iain S, McGregor, David E, Hibbs, Michelle, Glass, Richard C, Kevin, Samuel D, Banister
Publikováno v:
ACS chemical neuroscience. 13(8)
Synthetic cannabinoid receptor agonists (SCRAs) are a diverse class of new psychoactive substances (NPS). They commonly comprise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::99686cb6c755557c6af72a75338f7445
https://pubmed.ncbi.nlm.nih.gov/35404067
https://pubmed.ncbi.nlm.nih.gov/35404067
Autor:
Edward Pike, Richard C. Kevin, Roy Gerona, Ada Fang, Annelies Cannaert, Jia Lin Luo, Christophe P. Stove, Eric Sparkes, Ross Ellison, Samuel D. Banister
Publikováno v:
ACS Chemical Neuroscience. 11:4434-4446
Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive substances (NPS) with structurally diverse compounds emerging each year. Due to the rapid pace at which these drugs enter the market, there is often little or n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e961e1f27c1557f3ad46e9e7afd42975
https://doi.org/10.1021/acschemneuro.0c00644
https://doi.org/10.1021/acschemneuro.0c00644
Autor:
Edward, Pike, Katharina Elisabeth, Grafinger, Annelies, Cannaert, Adam, Ametovski, Jia Lin, Luo, Eric, Sparkes, Elizabeth A, Cairns, Ross, Ellison, Roy, Gerona, Christophe P, Stove, Volker, Auwärter, Samuel D, Banister
Publikováno v:
Drug testing and analysisREFERENCES. 13(7)
Synthetic cannabinoid receptor agonists (SCRAs) are one of the largest and most structurally diverse classes of new psychoactive substances (NPS). Despite this, pharmacological data are often lacking following the identification of a new SCRA in drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a26b1201c2dda500ddd19ddbcebfa7d6
https://pubmed.ncbi.nlm.nih.gov/33787091
https://pubmed.ncbi.nlm.nih.gov/33787091